Navigation Links
- Unigene Secures Financing to Extend Operating Runway in Conjunction with Strategic Reorganization -
Date:4/8/2013

BOONTON, N.J., April 8, 2013 /PRNewswire/ -- Unigene Laboratories, Inc. (PINK: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that the Company has entered into a second amendment to a financing agreement with affiliates of Victory Park Capital Advisors, LLC (VPC), whereby VPC has agreed to purchase an additional $750,000 senior secured note, providing Unigene with additional working capital. Under the terms of this financing, proceeds from the sale of the note, which is convertible into shares of UGNE common stock at a conversion price of $0.09 per share, will be used for working capital purposes.

In an effort to conserve capital and further extend its cash runway, Unigene also announced a strategic reorganization and downsizing, which involved a reduction of approximately 40% of its workforce. The majority of employees impacted by the reduction in workforce supported Unigene's Fortical® manufacturing and recombinant calcitonin production operations, which have been negatively impacted by regulatory recommendations in Europe and by an advisory committee to the U.S. Food and Drug Administration (FDA).  The company also disclosed that certain of its assets, primarily related to its Fortical® business, are impaired as a result of this regulatory activity and its related impact upon Fortical manufacturing revenues and royalties.  The asset impairment charges will be further discussed within the Company's reported financial results for the first quarter 2013.

Ashleigh Palmer , Unigene's Chief Executive Officer, stated, "We value VPC's ongoing support and willingness to continue financing the company.  Unigene remains focused on our efforts to conserve capital during these adverse conditions and challenging times.  We view the reduction in workforce as an
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin
2. Unigene to Announce Fourth Quarter and Full-Year 2011 Financial Results on March 8, 2012
3. Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award
4. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
5. Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011
6. VG Life Sciences, Inc. Secures Two-Year Funding Commitment and Administrative Support from MedBridge, LLC
7. Nabsys Secures $20 Million Series D Financing to Support Launch of Semiconductor-Based Single-Molecule Platform for Genomic Analysis
8. Unisense FertiliTech A/S Secures an Additional 20 Million USD in New Capital Investment
9. Blue Marble Biomaterials Secures Distribution Agreement with SAFC
10. K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization
11. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... , March 30, 2015 ... biological drugs to treat cancer, viral infections and ... Sir John Bell , the Regius Professor ... the Office for the Strategic Coordination of Health ... effect.      (Photo: http://photos.prnewswire.com/prnh/20150330/736483 ...
(Date:3/30/2015)... TOKYO and MADISON, Wis. ... Shigehiro Nakajima ,) (TSE: 4901) ("Fujifilm") and Cellular ... (NASDAQ: ICEL ) ("CDI"), a leading developer and ... to precise specifications, today announced that the two companies ... acquire CDI via an all-cash tender offer to be ...
(Date:3/29/2015)... 29, 2015 Caris Life Sciences® ... data showing the presence of PD-1 and ... samples. Using Caris Molecular Intelligence®, the company,s ... expression of programmed cell death protein-1 (PD-1) ... while its ligand (PD-L1) expression was variable ...
Breaking Biology Technology:Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4
... Mass., April 27, 2012  X-BODY BioSciences, Inc., a developer ... novel methods of selecting for antibodies against targets on ... Summit (PEGS) and the associated Biologics Partnering Forum being ... Richard Wagner, Ph.D., Co-Founder and Executive ...
... Inc., a privately-held biotech company using its proprietary platform ... of gastrointestinal diseases, announced today that it has elected ... Pharmaceuticals, Inc. to its Board of Directors. ... serve on our Board," said Dr. Barbara Fox, founder, ...
... April 26, 2012 Europe,s premier biotech ... OBN, the not-for-profit business network which provides ... South-East England biocluster and beyond, today announced the results ... Held from April 24 - 26 at Newbury Racecourse, ...
Cached Biology Technology:X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHI's Protein Engineering Summit 2Avaxia Biologics Elects Christopher Kiritsy to its Board of Directors 2Another Record Year for BioTrinity 2Another Record Year for BioTrinity 3
(Date:3/18/2015)... March 18, 2015 As mobile payments ... revolutionary smart wallets and apps continue to be introduced into ... in the mobile payment industry in focus today are:  NXT-ID, ... (NYSE: BABA ), Apple Inc. (NASDAQ: ... Facebook Inc. (NASDAQ: FB ) NXT-ID, ...
(Date:3/12/2015)... IriTech, a leading iris based identity management ... Instruments Design Network, announced today that the Chief Minister ... USB MK2120U device during a launching event of Andhra ... The iris scanner is manufactured by U.S. ... India through its Indian partner, Biometronic ...
(Date:3/11/2015)... 11, 2015   The Sync Project™ ... scientifically measure and harness music to improve health. ... and objective measurements of physiology, enabling the study ... in large populations. It is designed for medical ... perform rigorous studies and accelerate the discovery of ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... that the dinosaurs and most their contemporaries were not ... to a paleontologist who says multiple meteor impacts, massive ... end of the Cretaceous Period. , The Chicxulub ... earlier of a series of meteors and volcanic eruptions ...
... the explosive growth in size and complexity of the human ... genes expressed in brain tissue has actually slowed since the ... international research team reports in the December 26, 2006, issue ... the human brain, the authors maintain, has not been driven ...
... years of research, scientists at The University of Texas M. ... exquisite molecular detail, how the estrogen hormone can help keep ... of the journal, Nature Cell Biology, they assign roles to ... part in breast cancer cell survival, and in the process, ...
Cached Biology News:Far more than a meteor killed dinos 2Far more than a meteor killed dinos 3Complexity constrains evolution of human brain genes 2Complexity constrains evolution of human brain genes 3New path from estrogen to survival in breast cancer cells described 2New path from estrogen to survival in breast cancer cells described 3
... ATPase α-1, clone C464.6 GenBank Accession ... Na + /K + ATPase isolated ... medulla Formulation: 0.1M Tris-glycine, pH 7.4, 0.15M ... routinely evaluated in immunoblot on rat brain ...
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
EDG-1CT (endothelial cell differentiation gene-1, C terminal)...
Request Info...
Biology Products: